Outset Medical (OM) Preferred Stock Liabilities (2019 - 2020)

Outset Medical (OM) has reported Preferred Stock Liabilities for 2 consecutive years, with $452.3 million the latest figure, recorded in Q2 2020.

• On a quarterly basis, Preferred Stock Liabilities rose 10.8% year-over-year to $452.3 million in Q2 2020; TTM through Jun 2020 was $452.3 million, a 10.8% increase from a year earlier, with the FY2019 full-year figure at $409.4 million, up 4.37% from the prior year.
• Preferred Stock Liabilities was $452.3 million for Q2 2020 at Outset Medical, roughly flat from $452.3 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $452.3 million in Q1 2020 and troughed at $400.2 million in Q1 2019.